SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Progress Update

15 Feb 2010 07:00

RNS Number : 1159H
Ashley House PLC
15 February 2010
 



 

Progress Update

Following the interim results announced on 26 January Ashley House is pleased to confirm that two of its delayed projects (East London and Bristol) have now reached financial close releasing accrued revenue into cash. In addition the Company has completed as planned the sales of the minority LIFT investment stakes acquired with Sapphire in November 2009. The total proceeds from these disposals and the release of the accrued revenue has generated £3.34m in cash for Ashley House.

South East Resource Centre (SERC), Hackney East London

This 2,250m² building will accommodate primary and community care teams serving the South East of Hackney. Ithas a design-and-build value of £5.85m to Ashley House. This income will be recognised over the next 12 months. This resource centre is one of four projects in Hackney arising from the polyclinic programme. The schemes are delivered through the East London NHS LIFT Company in which Ashley House is a shareholder and development partner as well as design and build contractor for this scheme. Whilst the SERC project had been ready to go on site for some time the project was finally approved by NHS London (the Strategic Health Authority) as it announced plans for 100 polyclinics across London. Almost one third of these appear in NHS LIFT areas where Ashley House is the development partner.

South Bristol Community Hospital

This 11,000m² Community Hospital is being delivered through the Bristol LIFT Company where Ashley House is a shareholder and development partner. The project enables NHS Bristol to reconfigure service delivery in South Bristol. As with the East London SERC, the project has achieved financial close behind its first anticipated schedule and whilst bringing the Company a relatively small ongoing fee stream its approval releases the accrued income as cash and allows us to develop future opportunities with the PCT with renewed confidence.

The remaining three projects specifically referred to as having experienced delays in the interim results statement are expected to reach financial close in the coming weeks..

Sale of minority Sapphire LIFT investment interests

As reported in our statement of 26 Jan we had agreed to sell the minority NHS LIFT investment interests acquired with Sapphire to the other existing consortium partners. We are pleased to confirm that these sales have now completed.

Chief Executive Jonathan Holmes commented: "This has been a positive couple of weeks for Ashley House. The approval of delayed schemes following detailed review by a cost conscious NHS underlines the importance that moving care into community settings has in saving money whilst improving service to patients. The plan for 100 polyclinics has been re-affirmed by NHS London and working alongside our partners we have successfully closed our first project of a possible 30 arising from this programme alone."

Enquiries:

 

Ashley House plc

Jonathan Holmes, Chief Executive

Bruce Walker, Finance Director

 

Tel: 01628 600340

Numis Securities

(NOMAD and broker to Ashley House)

Oliver Cardigan/ Simon Blank/ David Poutney

 

Tel: 020 7260 1000

Citigate Dewe Rogerson

Sarah Gestetner / Ged Brumby

Tel: 020 7638 9571

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUVBRRAAUAAR
Date   Source Headline
12th Dec 20134:36 pmRNSHolding(s) in Company
10th Dec 20137:00 amRNSInterim report 2013
30th Sep 20133:45 pmRNSShare Options
12th Sep 20131:42 pmRNSHolding(s) in Company
11th Sep 20134:56 pmRNSHolding(s) in Company
10th Sep 20137:00 amRNSDirector Dealings
27th Aug 20131:52 pmRNSAppointment of Chairman
29th Jul 201310:56 amRNSResult of AGM
5th Jul 20137:00 amRNSPosting of Annual Report & Notice of AGM
25th Jun 20137:00 amRNSPreliminary Results
14th Jun 20137:00 amRNSHolding(s) in Company
12th Jun 20137:00 amRNSAppointment as Asset Manager and Sale of Projects
6th Jun 201310:00 amRNSAdmission as Member of the Social Stock Exchange
28th May 20133:16 pmRNSHolding(s) in Company
10th May 20137:00 amRNSTrading update, Board review and strategy progress
19th Apr 20133:44 pmRNSHolding(s) in Company
9th Apr 20133:40 pmRNSDirectorate Change
18th Mar 20134:53 pmRNSChange of Registered Office
11th Mar 20133:09 pmRNSDirectorate Changes
11th Feb 20131:26 pmRNSHolding(s) in Company
22nd Jan 20137:00 amRNSNominated Advisor & Broker / Report & Accounts
18th Dec 20127:00 amRNSInterim Results
20th Nov 201211:53 amRNSHolding(s) in Company
29th Oct 201212:42 pmRNSResult of AGM and statement
20th Sep 20127:00 amRNSReport and Accounts
25th Jul 20127:05 amRNSHolding(s) in Company
25th Jul 20127:00 amRNSPreliminary Results
11th Jun 20123:58 pmRNSHolding(s) in Company
7th Jun 201211:36 amRNSNotice of Results & Trading Update
29th May 201212:13 pmRNSDirectorate Change
1st May 20123:12 pmRNSTrading Update
25th Apr 201212:02 pmRNSDirector/PDMR Shareholding
12th Apr 20123:39 pmRNSDirector/PDMR Shareholding
21st Feb 20127:00 amRNSInterim Report and Accounts
9th Feb 20128:17 amRNSHolding(s) in Company
7th Feb 201211:18 amRNSDirector/PDMR Shareholding
31st Jan 20127:00 amRNSInterim Report 2011
28th Nov 20112:46 pmRNSBoard Changes
31st Oct 201110:06 amRNSReport and Accounts
24th Oct 201111:54 amRNSResult of AGM and Statement
8th Sep 201111:28 amRNSHolding(s) in Company
26th Jul 20112:51 pmRNSHolding(s) in Company
26th Jul 20117:00 amRNSFinal Results
13th May 20117:00 amRNSTrading Update and Notice of Results
14th Apr 20119:42 amRNSHolding(s) in Company
29th Mar 20114:18 pmRNSHolding(s) in Company
17th Mar 20114:14 pmRNSExercise of Options
17th Mar 20117:00 amRNSHolding(s) in Company
7th Mar 20117:00 amRNSReceipt of Assura monies and Special Interim Divi
18th Feb 201112:00 pmRNSResponse to Assura statement re AH Medical

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.